Pharmaceutical API Acarbose Used as an Anti- Diabetic CAS No. 56180-94-0

China Pharmaceutical API Acarbose Used as an Anti-Diabetic CAS No. 56180-94-0, Find details about China Acarbose, Acarbose Hydrate from Pharmaceutical API Acarbose Used as an Anti-Diabetic CAS No. 56180-94-0

Model NO.
56180-94-0
Other Names
Acarbose Hydrate
Molecular Formula
C25h43no18
Molecular Weight
645.6
Trademark
yc
Transport Package
Common
Specification
USP
Origin
China
Model NO.
56180-94-0
Other Names
Acarbose Hydrate
Molecular Formula
C25h43no18
Molecular Weight
645.6
Trademark
yc
Transport Package
Common
Specification
USP
Origin
China
 

Product name:
Acarbose

CAS:       
56180-94-0

EINECS:
260-030-7
Chemical Properties:Off-White Solid
Molecular Formula:C25H43NO18
Molecular Weight:645.6
Uses:Used as an anitdiabetic
An α-glucosidase inhibitor
Used as an anti-diabetic.
alpha-glucosidase & saccharase inhibitor, antidiabetes, antihyperlipidaemia, antiobesity
antipsychotic: 5HT antagonist, dopamine antagonist, H1-antihistamine, alpha adrenergic blocker
Acarbose is pseudo-oligosaccharide with a terminal C7-cyclitol patented in 1975 by Bayer. Acarbose is a component of the amylostatin complex produced by a species of Actinoplanes and Streptomyces. Acarbose acts as a potent inhibitor of alpha-glucosidases and saccharases. Since 1990, acarbose has been used therapeutically for the treatment of type 2 diabetes.
b-glucosidase inhibitor, antidiabetic
Acarbose is pseudo-oligosaccharide with a terminal C7-cyclitol patented in 1975 by Bayer. Acarbose is a component of the amylostatin complex produced by species of Actinoplanes and Streptomyces. Acarbose acts as a potent inhibitor of α-glucosidases and saccharases. Since 1990, acarbose has been used therapeutically for the treatment of type 2 diabetes.
Cardiovascular
Biological Activity:Inhibitor of intestinal α -glucosidase (IC 50 = 11 nM). Antidiabetic; inhibits the hydrolysis of complex carbohydrates.

Packaging Details:Delivery Detail:
Customize
within 2 weeks after receiving payments

Shanghai YUNG ZIP PHARM. TRADING Co., Ltd is a sole proprietorship which is set up in the economic center of mainland China by the largest pharmaceutical company of YUNG SHIN PHARM.IND.CO.,Ltd in Taiwan. Shanghai YUNG ZIP PHARM. TRADING Co., Ltd Founded on December 10, 1994, registered addresses in the Waigaoqiao Free Trade Zone Pudong, registered capital is USD 4 million,Main business areas including international trade, inter-enterprise trade and bonded within the agency, local storage and simple processing.